Data / Form D filings / TearSolutions, Inc.
TearSolutions, Inc.: Form D filings
TearSolutions, Inc., a biotechnology company in Charlottesville, VA, filed 14 Form D notices with the SEC between 2014 and 2025. The latest, on November 10, 2025, reports $517,000 sold of a $517,000 offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 315 Old Ivy Way, Suite 301, Charlottesville, VA, 22903
- Phone
- (434) 951-0444
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1611687
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | New notice | $517,000 | $517,000 | 12 | Oct 29, 2025 | sec.gov | |
| Oct 9, 2024 | New notice | $14,025,198 | $12,709,989 | $1,315,209 | 80 | Sep 25, 2024 | sec.gov |
| Aug 12, 2024 | New notice | $3,000,000 | $390,000 | $2,610,000 | 10 | Sep 8, 2023 | sec.gov |
| Jan 24, 2022 | New notice | $7,000,000 | $5,624,634 | $1,375,366 | 44 | Jul 16, 2021 | sec.gov |
| Feb 26, 2020 | New notice | $1,500,000 | $1,499,595 | $405 | 36 | Feb 12, 2020 | sec.gov |
| Apr 18, 2019 | Amendment | $5,118,562 | $5,118,562 | 22 | Mar 4, 2019 | sec.gov | |
| Apr 18, 2019 | Amendment | $1,332,364 | $1,332,364 | 16 | Mar 4, 2019 | sec.gov | |
| Mar 19, 2019 | New notice | $5,193,517 | $4,042,825 | $1,150,692 | 19 | Mar 4, 2019 | sec.gov |
| Mar 19, 2019 | New notice | $1,257,364 | $885,421 | $371,943 | 13 | Mar 4, 2019 | sec.gov |
| Dec 19, 2017 | New notice | $9,191,000 | $8,056,619 | $1,134,381 | 24 | Dec 4, 2017 | sec.gov |
| May 5, 2017 | Amendment | $5,320,668 | $3,410,334 | $1,910,334 | 22 | Jan 18, 2017 | sec.gov |
| Feb 24, 2017 | New notice | $1,500,000 | $1,080,346 | $419,654 | 12 | Jan 18, 2017 | sec.gov |
| Nov 12, 2014 | New notice | $3,000,000 | $500,000 | $2,500,000 | 1 | Oct 30, 2014 | sec.gov |
| Jun 25, 2014 | New notice | $1,000,000 | $390,000 | $610,000 | 5 | May 6, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James M Ramey | Director | |
| Amir W Shojaei | Director | |
| Colin M Rolph | Executive Officer | |
| Gordon W Laurie | Executive Officer | |
| Robert J Dempsey | Executive Officer, Director | |
| Mark B Logan | Director | |
| Anil W Asrani | Executive Officer, Director | |
| Jens W Biertumpel | Director | |
| Louis M Alpern | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Nov 10, 2025 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TearSolutions, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.